159 related articles for article (PubMed ID: 23397147)
1. Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.
Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Sasaki K; Sasaki A; Ohki H; Takakubo N; Konttinen YT; Takagi M
Clin Rheumatol; 2013 Jun; 32(6):853-61. PubMed ID: 23397147
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis.
Li X; Xu T; Wang Y; Huang C; Li J
Clin Rheumatol; 2014 Feb; 33(2):291-2. PubMed ID: 24258070
[No Abstract] [Full Text] [Related]
3. Distribution of Podoplanin in Synovial Tissues in Rheumatoid Arthritis Patients Using Biologic or Conventional Disease-Modifying Anti-Rheumatic Drugs.
Takakubo Y; Oki H; Naganuma Y; Saski K; Sasaki A; Tamaki Y; Suran Y; Konta T; Takagi M
Curr Rheumatol Rev; 2017; 13(1):72-78. PubMed ID: 27030253
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis.
Kim JW; Kong JS; Lee S; Yoo SA; Koh JH; Jin J; Kim WU
Exp Mol Med; 2020 May; 52(5):843-853. PubMed ID: 32461558
[TBL] [Abstract][Full Text] [Related]
5. General synovitis score and immunologic synovitis score reflect clinical disease activity in patients with advanced stage rheumatoid arthritis.
Schmidt T; Najm A; Mussawy H; Burghardt R; Oehler N; Krenn V; Rüther W; Niemeier A
Sci Rep; 2019 Jun; 9(1):8448. PubMed ID: 31186464
[TBL] [Abstract][Full Text] [Related]
6. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
[TBL] [Abstract][Full Text] [Related]
7. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
8. Subclinical synovitis measured by ultrasound in rheumatoid arthritis patients with clinical remission induced by synthetic and biological modifying disease drugs.
Cruces M; Al Snih S; Serra-Bonett N; Rivas JC
Reumatol Clin (Engl Ed); 2019; 15(4):218-222. PubMed ID: 29032909
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis.
Zhu LJ; Dai L; Zheng DH; Mo YQ; Ou-Yang X; Wei XN; Shen J; Zhang BY
Arthritis Res Ther; 2012 Jun; 14(3):R133. PubMed ID: 22656185
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and vascularisation markers of arthroscopically-guided finger joint synovial biospies reflect global disease activity in rheumatoid arthritis.
Vordenbäumen S; Sewerin P; Lögters T; Miese F; Schleich C; Bleck E; Philippski P; Schädel-Höpfner M; Pauly T; Schneider M; Ostendorf B
Clin Exp Rheumatol; 2014; 32(1):117-20. PubMed ID: 24387883
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
12. Relation of Doppler ultrasound synovitis versus clinical synovitis with changes in native complement component levels in rheumatoid arthritis patients treated with biologic disease-modifying anti-rheumatic drugs.
Montoro Alvarez M; Chong OY; Janta I; González C; López-Longo J; Monteagudo I; Valor L; Garrido J; Lau IS; Rosman A; Naredo E; Carreño L
Clin Exp Rheumatol; 2015; 33(2):141-5. PubMed ID: 25665178
[TBL] [Abstract][Full Text] [Related]
13. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J
Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439
[TBL] [Abstract][Full Text] [Related]
15. Change in CD3 positive T-cell expression in psoriatic arthritis synovium correlates with change in DAS28 and magnetic resonance imaging synovitis scores following initiation of biologic therapy--a single centre, open-label study.
Pontifex EK; Gerlag DM; Gogarty M; Vinkenoog M; Gibbs A; Burgman I; Fearon U; Bresnihan B; Tak PP; Gibney RG; Veale DJ; FitzGerald O
Arthritis Res Ther; 2011 Jan; 13(1):R7. PubMed ID: 21272347
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound Assessment of Disease Activity Prevents Disease-Modifying Antirheumatic Drug (DMARD) Escalation and May Reduce DMARD-Related Direct Costs in Rheumatoid Arthritis With Fibromyalgia: An Exploratory Study.
Silva Chakr RMD; Santos JCO; Alves LDS; de Andrade NPB; Ranzolin A; Brenol CV
J Ultrasound Med; 2020 Jul; 39(7):1271-1278. PubMed ID: 31958164
[TBL] [Abstract][Full Text] [Related]
17. Outcome of rheumatoid arthritis following adjunct statin therapy.
Das S; Mohanty M; Padhan P
Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950
[TBL] [Abstract][Full Text] [Related]
18. [Expression of peroxisome proliferator-activated receptor-gamma coactivator 1β in synovium in patients with rheumatoid arthritis and its clinical significance].
Wei XN; Zhang XP; Yang LJ; Jing J; Wang JW; Wu T; Ma JD; Lin JZ; Zheng DH; Dai L
Zhonghua Yi Xue Za Zhi; 2021 Feb; 101(5):327-332. PubMed ID: 34645250
[No Abstract] [Full Text] [Related]
19. The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release.
Asquith DL; Ballantine LE; Nijjar JS; Makdasy MK; Patel S; Wright PB; Reilly JH; Kerr S; Kurowska-Stolarska M; Gracie JA; McInnes IB
Ann Rheum Dis; 2013 Dec; 72(12):2024-31. PubMed ID: 23434566
[TBL] [Abstract][Full Text] [Related]
20. Type I interferons might form the link between Toll-like receptor (TLR) 3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis (RA).
Roelofs MF; Wenink MH; Brentano F; Abdollahi-Roodsaz S; Oppers-Walgreen B; Barrera P; van Riel PL; Joosten LA; Kyburz D; van den Berg WB; Radstake TR
Ann Rheum Dis; 2009 Sep; 68(9):1486-93. PubMed ID: 18765427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
